BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 22679189)

  • 1. Treatment of polyglandular autoimmune syndrome type 3 using co-transplantation of insulin-secreting mesenchymal stem cells and haematopoietic stem cells.
    Trivedi HL; Thakkar UG; Vanikar AV; Dave SD
    BMJ Case Rep; 2011 Sep; 2011():. PubMed ID: 22679189
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Insulin-secreting adipose-derived mesenchymal stromal cells with bone marrow-derived hematopoietic stem cells from autologous and allogenic sources for type 1 diabetes mellitus.
    Thakkar UG; Trivedi HL; Vanikar AV; Dave SD
    Cytotherapy; 2015 Jul; 17(7):940-7. PubMed ID: 25869301
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Novel therapy for insulin-dependent diabetes mellitus: infusion of in vitro-generated insulin-secreting cells.
    Dave SD; Vanikar AV; Trivedi HL; Thakkar UG; Gopal SC; Chandra T
    Clin Exp Med; 2015 Feb; 15(1):41-5. PubMed ID: 24317657
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Co-infusion of autologous adipose tissue derived insulin-secreting mesenchymal stem cells and bone marrow derived hematopoietic stem cells: viable therapy for type III.C. a diabetes mellitus.
    Thakkar UG; Vanikar AV; Trivedi HL
    Biomed J; 2013; 36(6):304-7. PubMed ID: 24385073
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Combined therapy of insulin-producing cells and haematopoietic stem cells offers better diabetic control than only haematopoietic stem cells' infusion for patients with insulin-dependent diabetes.
    Dave SD; Trivedi HL; Gopal SC; Chandra T
    BMJ Case Rep; 2014 Sep; 2014():. PubMed ID: 25199184
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cotransplantation of adipose tissue-derived insulin-secreting mesenchymal stem cells and hematopoietic stem cells: a novel therapy for insulin-dependent diabetes mellitus.
    Vanikar AV; Dave SD; Thakkar UG; Trivedi HL
    Stem Cells Int; 2010 Dec; 2010():582382. PubMed ID: 21197448
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Human adipose tissue-derived mesenchymal stem cells combined with hematopoietic stem cell transplantation synthesize insulin.
    Trivedi HL; Vanikar AV; Thakker U; Firoze A; Dave SD; Patel CN; Patel JV; Bhargava AB; Shankar V
    Transplant Proc; 2008 May; 40(4):1135-9. PubMed ID: 18555133
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Co-infusion of adipose tissue derived mesenchymal stem cell-differentiated insulin-making cells and haematopoietic cells with renal transplantation: a novel therapy for type 1 diabetes mellitus with end-stage renal disease.
    Dave SD; Vanikar AV; Trivedi HL
    BMJ Case Rep; 2013 May; 2013():. PubMed ID: 23709153
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Management of type 1 diabetes mellitus using in vitro autologous adipose tissue trans-differentiated insulin-making cells.
    Dave SD; Trivedi HL; Chooramani SG; Chandra T
    BMJ Case Rep; 2013 Jul; 2013():. PubMed ID: 23893283
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Co-infusion of donor adipose tissue-derived mesenchymal and hematopoietic stem cells helps safe minimization of immunosuppression in renal transplantation - single center experience.
    Vanikar AV; Trivedi HL; Kumar A; Gopal SC; Patel HV; Gumber MR; Kute VB; Shah PR; Dave SD
    Ren Fail; 2014 Oct; 36(9):1376-84. PubMed ID: 25246338
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy of Autologous Bone Marrow-Derived Mesenchymal Stem Cell and Mononuclear Cell Transplantation in Type 2 Diabetes Mellitus: A Randomized, Placebo-Controlled Comparative Study.
    Bhansali S; Dutta P; Kumar V; Yadav MK; Jain A; Mudaliar S; Bhansali S; Sharma RR; Jha V; Marwaha N; Khandelwal N; Srinivasan A; Sachdeva N; Hawkins M; Bhansali A
    Stem Cells Dev; 2017 Apr; 26(7):471-481. PubMed ID: 28006991
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mesenchymal stem cells: Stem cell therapy perspectives for type 1 diabetes.
    Vija L; Farge D; Gautier JF; Vexiau P; Dumitrache C; Bourgarit A; Verrecchia F; Larghero J
    Diabetes Metab; 2009 Apr; 35(2):85-93. PubMed ID: 19230736
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of co-transplantation of mesenchymal stem cells and hematopoietic stem cells as compared to hematopoietic stem cell transplantation alone in renal transplantation to achieve donor hypo-responsiveness.
    Vanikar AV; Trivedi HL; Feroze A; Kanodia KV; Dave SD; Shah PR
    Int Urol Nephrol; 2011 Mar; 43(1):225-32. PubMed ID: 20084457
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Umbilical Cord Mesenchymal Stromal Cell With Autologous Bone Marrow Cell Transplantation in Established Type 1 Diabetes: A Pilot Randomized Controlled Open-Label Clinical Study to Assess Safety and Impact on Insulin Secretion.
    Cai J; Wu Z; Xu X; Liao L; Chen J; Huang L; Wu W; Luo F; Wu C; Pugliese A; Pileggi A; Ricordi C; Tan J
    Diabetes Care; 2016 Jan; 39(1):149-57. PubMed ID: 26628416
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Autologous nonmyeloablative hematopoietic stem cell transplantation in new-onset type 1 diabetes: a multicenter analysis.
    D'Addio F; Valderrama Vasquez A; Ben Nasr M; Franek E; Zhu D; Li L; Ning G; Snarski E; Fiorina P
    Diabetes; 2014 Sep; 63(9):3041-6. PubMed ID: 24947362
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vitro Generated Mesenchymal Stem Cells: Suitable Tools to Target Insulin Dependent Diabetes Mellitus?
    Dave SD; Patel CN; Patel JV; Thakkar UG
    Curr Stem Cell Res Ther; 2017; 12(4):288-299. PubMed ID: 27903221
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Autologous bone marrow-derived rat mesenchymal stem cells promote PDX-1 and insulin expression in the islets, alter T cell cytokine pattern and preserve regulatory T cells in the periphery and induce sustained normoglycemia.
    Boumaza I; Srinivasan S; Witt WT; Feghali-Bostwick C; Dai Y; Garcia-Ocana A; Feili-Hariri M
    J Autoimmun; 2009 Feb; 32(1):33-42. PubMed ID: 19062254
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Insulin-secreting cells from human eyelid-derived stem cells alleviate type I diabetes in immunocompetent mice.
    Kang HM; Kim J; Park S; Kim J; Kim H; Kim KS; Lee EJ; Seo SI; Kang SG; Lee JE; Lim H
    Stem Cells; 2009 Aug; 27(8):1999-2008. PubMed ID: 19544420
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mesenchymal stromal cells enhance the engraftment of hematopoietic stem cells in an autologous mouse transplantation model.
    Fernández-García M; Yañez RM; Sánchez-Domínguez R; Hernando-Rodriguez M; Peces-Barba M; Herrera G; O'Connor JE; Segovia JC; Bueren JA; Lamana ML
    Stem Cell Res Ther; 2015 Sep; 6(1):165. PubMed ID: 26345192
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Secretion of anterior pituitary hormones in patients with insulin-dependent diabetes mellitus and polyglandular autoimmune syndrome.
    Kurokawa H; Numata Y; Nishioka T; Takao T; Hashimoto K
    Intern Med; 1996 Sep; 35(9):686-92. PubMed ID: 8915692
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.